"Clinical Study Phase II trial of radiotherapy, hormone therapy and chemotherapy with radiotherapy and hormone therapy versus docetaxel in patients with localized prostate cancer at high risk (stage III and IV)

Trial Profile

"Clinical Study Phase II trial of radiotherapy, hormone therapy and chemotherapy with radiotherapy and hormone therapy versus docetaxel in patients with localized prostate cancer at high risk (stage III and IV)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Jun 2015

At a glance

  • Drugs Docetaxel (Primary) ; Hormone antagonists
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top